126 related articles for article (PubMed ID: 16734978)
1. An investigation into the adjuvanticity and immunogenicity of zein microspheres being researched as drug and vaccine carriers.
Hurtado-López P; Murdan S
J Pharm Pharmacol; 2006 Jun; 58(6):769-74. PubMed ID: 16734978
[TBL] [Abstract][Full Text] [Related]
2. Colonic antigen administration induces significantly higher humoral levels of colonic and vaginal IgA, and serum IgG compared to oral administration.
McConnell EL; Basit AW; Murdan S
Vaccine; 2008 Jan; 26(5):639-46. PubMed ID: 18178292
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
4. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
5. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice].
Huang XG; Xu JQ; Ren L; Qiu C; Zhang N; Liu LX; Wan YM; Peng H; Shao YM
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3109-13. PubMed ID: 17313761
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system.
Hori M; Onishi H; Machida Y
Int J Pharm; 2005 Jun; 297(1-2):223-34. PubMed ID: 15885938
[TBL] [Abstract][Full Text] [Related]
7. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis.
Khan AA; Babu JP; Gupta G; Rao DN
Vaccine; 2008 Jan; 26(3):316-32. PubMed ID: 18096277
[TBL] [Abstract][Full Text] [Related]
8. Combination of immune stimulating adjuvants with poly(lactide-co-glycolide) microspheres enhances the immune response of vaccines.
Salvador A; Igartua M; Hernández RM; Pedraz JL
Vaccine; 2012 Jan; 30(3):589-96. PubMed ID: 22119926
[TBL] [Abstract][Full Text] [Related]
9. In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT.
Kang ML; Kang SG; Jiang HL; Shin SW; Lee DY; Ahn JM; Rayamahji N; Park IK; Shin SJ; Cho CS; Yoo HS
Eur J Pharm Biopharm; 2006 Jun; 63(2):215-20. PubMed ID: 16531027
[TBL] [Abstract][Full Text] [Related]
10. Detection of anti-ovalbumin IgG in serum by immune complex transfer enzyme immunoassay.
Hirota K; Kamashima T; Totani M
Clin Lab; 2001; 47(5-6):213-7. PubMed ID: 11405598
[TBL] [Abstract][Full Text] [Related]
11. Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio cholerae.
Nygren E; Holmgren J; Attridge SR
Vaccine; 2008 Dec; 26(52):6784-90. PubMed ID: 18951939
[TBL] [Abstract][Full Text] [Related]
12. Immune complex transfer enzyme immunoassay for anti-ovalbumin IgA in serum.
Hirota K; Kamashima T; Hashida S; Totani M
Ann Clin Biochem; 2002 Sep; 39(Pt 5):482-6. PubMed ID: 12227854
[TBL] [Abstract][Full Text] [Related]
13. Transcutaneous immunization using common chemicals.
Karande P; Arora A; Pham TK; Stevens D; Wojicki A; Mitragotri S
J Control Release; 2009 Sep; 138(2):134-40. PubMed ID: 19426770
[TBL] [Abstract][Full Text] [Related]
14. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
Bessa J; Schmitz N; Hinton HJ; Schwarz K; Jegerlehner A; Bachmann MF
Eur J Immunol; 2008 Jan; 38(1):114-26. PubMed ID: 18081037
[TBL] [Abstract][Full Text] [Related]
15. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
[TBL] [Abstract][Full Text] [Related]
16. Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents.
Peng Z; Liu Q; Wang Q; Rector E; Ma Y; Warrington R
Clin Exp Allergy; 2007 Jul; 37(7):1040-8. PubMed ID: 17581197
[TBL] [Abstract][Full Text] [Related]
17. Mucosal or systemic administration of rE2 glycoprotein antigen loaded PLGA microspheres.
Brandhonneur N; Loizel C; Chevanne F; Wakeley P; Jestin A; Le Potier MF; Le Corre P
Int J Pharm; 2009 May; 373(1-2):16-23. PubMed ID: 19429284
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Size, Dose, and Administration Route on Zein Nanoparticle Immunogenicity in BALB/c Mice.
Li F; Chen Y; Liu S; Pan X; Liu Y; Zhao H; Yin X; Yu C; Kong W; Zhang Y
Int J Nanomedicine; 2019; 14():9917-9928. PubMed ID: 31908449
[TBL] [Abstract][Full Text] [Related]
19. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
20. Protective immunization in mice against group B streptococci using encapsulated C5a peptidase.
Santillan DA; Andracki ME; Hunter SK
Am J Obstet Gynecol; 2008 Jan; 198(1):114.e1-6. PubMed ID: 17905172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
